XML 57 R45.htm IDEA: XBRL DOCUMENT
v3.21.2

Fair Value Measurements (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2021 | Dec. 31, 2020
Fair Value Disclosures [Abstract] |  |
Schedule of Warrant Derivative Liabilities | The following table presents the assumptions used for the warrant derivative liabilities under the Black-Scholes option-pricing model: Schedule of Warrant Derivative Liabilities
|  | As of June 30, 2021 |  |  | As of December 31, 2020 |
|  | Strome Warrants |  |  | B. Riley Warrants |  |  | Strome Warrants |  |  | B. Riley Warrants |
Expected life |  |  | 1.96 |  |  |  | 4.30 |  |  |  | 2.45 |  |  |  | 4.79 |
Risk-free interest rate |  |  | 0.25 | % |  |  | 0.67 | % |  |  | 0.13 | % |  |  | 0.36 | %
Volatility factor |  |  | 147.10 | % |  |  | 134.44 | % |  |  | 150.55 | % |  |  | 140.95 | %
Dividend rate |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | %
Transaction date closing market price |  | $ | 0.78 |  |  | $ | 0.78 |  |  | $ | 0.60 |  |  | $ | 0.60 |
Exercise price |  | $ | 0.50 |  |  | $ | 1.00 |  |  | $ | 0.50 |  |  | $ | 1.00 |
Schedule of Valuation Activity for Warrants Accounted for Derivative Liability | The following table represents the carrying amounts and change in valuation for the Company’s warrants accounted for as a derivative liability and classified within Level 3 of the fair-value hierarchy: Schedule of Valuation Activity for Warrants Accounted for Derivative Liability
|  | As of and for the Six Months Ended June 30, 2021 |  |  | As of and for the Six Months Ended June 30, 2020 |
|  | Carry Amount at Beginning of Period |  |  | Change in Valuation |  |  | Carrying Amount at End of Period |  |  | Carry Amount at Beginning of Period |  |  | Change in Valuation |  |  | Carrying Amount at End of Period |
Strome Warrants |  | $ | 704,707 |  |  | $ | 185,156 |  |  | $ | 889,863 |  |  | $ | 1,036,687 |  |  | $ | (260,345 | ) |  | $ | 776,342 |
B. Riley Warrants |  |  | 443,188 |  |  |  | 119,787 |  |  |  | 562,975 |  |  |  | 607,513 |  |  |  | (122,150 | ) |  |  | 485,363 |
Total |  | $ | 1,147,895 |  |  | $ | 304,943 |  |  | $ | 1,452,838 |  |  | $ | 1,644,200 |  |  | $ | (382,495 | ) |  | $ | 1,261,705 |
| The following table represents the carrying amount, valuation and roll-forward of activity for the Company’s warrants accounted for as a derivative liability and classified within Level 3 of the fair-value hierarchy as of and for the years ended December 31, 2020 and 2019: Schedule of Valuation Activity for Warrants Accounted for Derivative Liability
|  | December 31, |
|  | 2020 |  |  | 2019 |
Carrying amount at beginning of year: |  |  |  |  |  |  |  |
L2 Warrants |  | $ | - |  |  | $ | 418,214 |
Strome Warrants |  |  | 1,036,687 |  |  |  | 587,971 |
B. Riley Warrants |  |  | 607,513 |  |  |  | 358,050 |
Subtotal carrying amount at beginning of year |  |  | 1,644,200 |  |  |  | 1,364,235 |
Change in valuation of warrant derivative liabilities: |  |  |  |  |  |  |  |
L2 Warrants |  |  | - |  |  |  | 316,972 |
Strome Warrants |  |  | (331,980 | ) |  |  | 448,716 |
B. Riley Warrants |  |  | (164,325 | ) |  |  | 249,463 |
Subtotal change in valuation during the year |  |  | (496,305 | ) |  |  | 1,015,151 |
Exercise of warrants during the year: |  |  |  |  |  |  |  |
L2 Warrants |  |  | - |  |  |  | 735,186 |
Carrying amount at end of year: |  |  |  |  |  |  |  |
Strome Warrants |  |  | 704,707 |  |  |  | 1,036,687 |
B. Riley Warrants |  |  | 443,188 |  |  |  | 607,513 |
Carrying amount at end of year |  | $ | 1,147,895 |  |  | $ | 1,644,200 |
Schedule of Fair Value of Financial Instruments |  | Financial instruments measured at fair value during the year consisted of the following as of December 31, 2020 and 2019: Schedule of Fair Value of Financial Instruments
|  | Year Ended December 31, 2020 |
|  | Fair Value |  |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
Long-term debt: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
12% Amended Senior Secured Notes |  | $ | 52,556,401 |  |  | $ | - |  |  | $ | 52,556,401 |  |  | $ | - |
Warrant derivative liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Strome Warrants |  | $ | 704,707 |  |  | $ | - |  |  | $ | - |  |  | $ | 704,707 |
B. Riley Warrants |  |  | 443,188 |  |  |  | - |  |  |  | - |  |  |  | 443,188 |
Total warrant derivative liabilities |  | $ | 1,147,895 |  |  | $ | - |  |  | $ | - |  |  | $ | 1,147,895 |
|  | Year Ended December 31, 2019 |
|  | Fair Value |  |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
Long-term debt: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
12% Amended Senior Secured Notes |  | $ | 44,009,745 |  |  | $ | - |  |  | $ | 44,009,745 |  |  | $ | - |
Warrant derivative liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Strome Warrants |  | $ | 1,036,687 |  |  | $ | - |  |  | $ | - |  |  | $ | 1,036,687 |
B. Riley Warrants |  |  | 607,513 |  |  |  | - |  |  |  | - |  |  |  | 607,513 |
Total warrant derivative liabilities |  | $ | 1,644,200 |  |  | $ | - |  |  | $ | - |  |  | $ | 1,644,200 |
Embedded derivative liabilities |  | $ | 13,501,000 |  |  | $ | - |  |  | $ | - |  |  | $ | 13,501,000 |
Schedule of Valuation Activity for the Embedded Conversion Feature Liability |  | The following table represents the carrying amount, valuation and a roll-forward of activity for the conversion option features, buy-in features, and default remedy features, as deemed appropriate for each instrument (collectively the embedded derivative liabilities), for the 12% Convertible Debentures (refer to Note 18) accounted for as embedded derivative liabilities and classified within Level 3 of the fair-value hierarchy as of and for the years ended December 31, 2020 and 2019: Schedule of Valuation Activity for the Embedded Conversion Feature Liability
|  | December 31, |
|  | 2020 |  |  | 2019 |
Recognition of embedded derivative liabilities (conversion feature, buy-in feature, and default remedy feature): |  |  |  |  |  |  |  |
Carrying amount at beginning of year |  | $ | 13,501,000 |  |  | $ | 7,387,000 |
Issuance date of March 18, 2019 |  |  | - |  |  |  | 822,000 |
Issuance date of March 27, 2019 |  |  | - |  |  |  | 188,000 |
Issuance date of April 8, 2019 |  |  | - |  |  |  | 64,000 |
Change in fair value of embedded derivative liabilities |  |  | (2,571,004 | ) |  |  | 5,040,000 |
Fair value of embedded derivative liabilities recorded within additional paid-capital upon conversion of 12% convertible debentures |  |  | (10,929,996 | ) |  |  | - |
Carrying amount at end of year |  | $ | - |  |  | $ | 13,501,000 |

X
- References No definition available. + Details
Name: | MVEN_ScheduleOfValuationActivityForEmbeddedConversionFeatureLiabilityTableTextBlock
Namespace Prefix: | MVEN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Valuation Activity For Warrants Accounted For Derivative Liability [TableTextBlock] + References No definition available. + Details
Name: | MVEN_ScheduleOfValuationActivityForWarrantsAccountedForDerivativeLiabilityTableTextBlock
Namespace Prefix: | MVEN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Warrant Derivative Liabilities [TableTextBlock] + References No definition available. + Details
Name: | MVEN_ScheduleOfWarrantDerivativeLiabilitiesTableTextBlock
Namespace Prefix: | MVEN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration